Results 61 to 70 of about 274,562 (162)

Metabolic Syndrome and Associated Kidney Disease

, 2012
With the rise in the incidence of childhood obesity, it is increasingly ­evident that the burden of chronic kidney disease (CKD) has increased proportionately and has its origins in early life.
Wacharee Seeherunvong, Carolyn L. Abitbol, Seeherunvong, Wacharee, Abitbol, Carolyn L   +3 more
core   +1 more source

Low Cardiorespiratory Fitness is an Independent Predictor of Metabolic Syndrome in Young Korean Adults

, 2008
Objective: To investigate the relationship between cardio/respiratory fitness (CRF) and metabolic syndrome (MS) in young Korean men. Design: In a cross-sectional study, we examined 909 young Korean men (mean±SD age, 24.0±2 years) who were ...
Hyun-Sik Kang, Soo-Hyun Park, Shinuk Kim
core  

Genetic variants and the metabolic syndrome: a systematic review

, 2011
Several candidate gene studies on the metabolic syndrome (MetS) have been conducted. However, for most single nucleotide polymorphisms (SNPs) no systematic review on their association with MetS exists.
Boer, J.M., Feskens, E.J.M., Povel, C.M.
core   +1 more source

Targeting components of the stress system as potential therapies for the metabolic syndrome - The peroxisome-proliferator-activated receptors

, 2021
The three peroxisome-proliferator-activated receptor (PPAR) subtypes PPAR-alpha, PPAR-gamma, and PPAR-delta are ligand-activated transcription factors of the nuclear receptor family.
Yumuk, Volkan Demirhan
core   +1 more source

Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study [PDF]

, 2012
AIMS/HYPOTHESIS: Vasopressin plays a role in osmoregulation, glucose homeostasis and inflammation. Therefore, plasma copeptin, the stable C-terminal portion of the precursor of vasopressin, has strong potential as a biomarker for the cardiometabolic ...
Gansevoort, R.T., Bakker, S.J., Corpeleijn, E.; id_orcid, Postmus, D.; id_orcid, Postmus, D., Bakker, S. J. L.; id_orcid, Navis, G., Stolk, R.P., Hillege, H.L., Stolk, R. P.; id_orcid, Bakker, S. J. L., Gansevoort, R. T., Gans, R. O. B.; id_orcid, Corpeleijn, E., Gans, R. O. B., Stolk, R. P., Gans, R.O., Abbasi, A., Meijer, E., Hillege, H. L., Struck, J.   +20 more
core   +1 more source

Increased Prevalence of Metabolic Syndrome in Patients with Psoriatic Arthritis

, 2014
Objective: The increased incidence of cardiovascular disease (CVD) in patients with psoriatic arthritis (PsA) has been reported previously. We aimed to evaluate the presence of metabolic syndrome and to assess the insulin resistance associated with ...
Bahadir, Cengiz, Pehlevan, Yekta, Pehlevan, Seval, Goktay, Fatih, Ince, Nurhan, Yetkin, Demet Ozgil, Kayatas, Kadir   +6 more
core   +1 more source

Role of Sodium-Glucose Transport Protein-2 Inhibitors in Renal Protection: A Narrative Review from the Cardiovascular-Kidney-Metabolic Interconnection

Drug Design, Development and Therapy
Nan Ye, Hong Cheng Department of Nephrology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Hong Cheng, Department of Nephrology, Beijing Anzhen Hospital, Capital Medical University, No.
Ye N, Cheng H
doaj  

Cardiovascular-Kidney-Metabolic Syndrome: An Update for Clinician

Jurnal Penyakit Dalam Indonesia
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic abnormality resulting from complex pathophysiological interactions among cardiovascular disease, chronic kidney disease, and metabolic risk factors, particularly diabetes mellitus and obesity ...
Muhammad Yamin, Harits Adi Putra
doaj   +1 more source

Prevalencia de síndrome metabólico y relación con eventos cardiovasculares, supervivencia y función del injerto en pacientes con trasplante renal

Revista Colombiana de Cardiología, 2017
Resumen: Introducción: el síndrome metabólico en pacientes trasplantados tiene una prevalencia entre 20 a 65%1. Objetivo: estimar la prevalencia de síndrome metabólico al momento del trasplante renal y su asociación con el desarrollo de eventos ...
Paola K. García, Juan S. Gélvez, Karen Navarro, Kateir Contreras, Martha P. Rodríguez, Camilo González   +5 more
doaj   +1 more source

Cholesterol Goal Attainment in Hypertensive Patients: the Impact of Metabolic Syndrome Components

, 2012
Background: Hypertension and dyslipidemia are potentially modifiable cardiovascular risk factors.Methods: We studied hypertensive outpatients regarding goal attainment in controlling dyslipidemia, according to individual cardiovascular risk profile ...
Batista, Marcelo Costa, Ribeiro, Hercules Ferreira, Oliveira Rodrigues, Cassio Jose de [UNIFESP], Zanella, Maria Teresa, Ribeiro, Artur Beltrame   +4 more
core   +1 more source